Arca
Skip to content
Tools
Tools

Cyanide

Small molecule that 2 drugs act on.

  • Drugs that act on it: 2
  • Approved: 1
  • In phases 1 to 3: 1
  • Sponsors: 1

Who is on it, and how far along

Every drug ChEMBL records acting on this target, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 2

Approved1

  • Hydroxocobalamin

Phase 30

    Phase 21

    • Dicobalt edetate

    Phase 10

      The landscape

      Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
      HydroxocobalaminApprovedBoston ScientificSmall moleculeSequestering agentCyanide sequestering agent110
      Dicobalt edetatePhase 2—Small moleculeSequestering agentCyanide sequestering agent0

      Open trials

      The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 8 in all, from ClinicalTrials.gov.
      Systemic Inflammatory and Metabolic Biomarkers of Peri-Implant Diseases in Postmenopausal WomenHydroxocobalamin—RecruitingKübra Hazal BilginNov 20, 2026
      Interleukin 6 Versus Lactic Acid in Septic ShockHydroxocobalaminNot applicableNot yet recruitingNew Valley UniversityNov 19, 2026
      Persistent Vitamin B12 Hypervitaminemia: Identification of Biomarkers for the Early Detection of Solid CancersHydroxocobalaminNot applicableNot yet recruitingUniversity Hospital, AngersNov 17, 2026
      Effectiveness and Safety of Cellbooster Hair in Healthy SubjectsHydroxocobalaminNot applicableNot yet recruitingSuisselleNov 10, 2026
      Oral B-Complex Vitamin (B6, B9 and B12) Prevents Low Anterior Resection Syndrome in Rectal Cancer Patients With HyperhomocysteinemiaHydroxocobalaminNot applicableNot yet recruitingQilu Hospital of Shandong UniversityNov 10, 2026
      Effectiveness of Oxitard Gel Versus Physiotherapeutic and Pharmacological Interventions in Alleviating Oral Submucous Fibrosis: A Phase-II Randomized Control TrialHydroxocobalaminPhase 2Not yet recruitingDow University of Health SciencesNov 6, 2026
      Stanford University Neurofiber StudyHydroxocobalaminPhase 1Not yet recruitingStanford UniversityNov 3, 2026
      Methyl Donor-Rich Diet in the Postpartum PeriodHydroxocobalaminNot applicableRecruitingIstanbul University - CerrahpasaOct 21, 2026

      Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL4632347, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

      Esc

      Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

      Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.